Form D · Biotechnology
Transomic Technologies, Inc.
Huntsville, AL · CIK 0001539876
Offering snapshot reported Apr 14, 2015 · SEC filing
- Reported sold
- $1.12M Offering amount: $1.52M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jun 12, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 10
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2015 | Amendment | $1,115,600 | No comparison | 10 | SEC filing |
| May 21, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 17, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Mar 8, 2012 | Initial | $20,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-217747
Source: Form D, filed Apr 14, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason K Chung | Director |
| Rusla Marianne Du Breuil | Director, Executive |
| Gwen Diedre Fewell | Director, Executive |
| James Robert Hudson, Jr. | Director |
| David Troy Moore | Director |
| Blake De Witt Simmons | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
601 Genome Way Suite 1222
Huntsville, AL, 35806
Huntsville, AL, 35806